Igor Koralnik to Male
This is a "connection" page, showing publications Igor Koralnik has written about Male.
Connection Strength
2.141
-
Evolution of neurologic symptoms in non-hospitalized COVID-19 "long haulers". Ann Clin Transl Neurol. 2022 07; 9(7):950-961.
Score: 0.066
-
LTA4H Prevalence and Mortality in Adult Zambians with Tuberculous Meningitis. Ann Neurol. 2021 12; 90(6):994-998.
Score: 0.063
-
Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021 05; 8(5):1073-1085.
Score: 0.061
-
Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020 11; 7(11):2221-2230.
Score: 0.059
-
Children with Narcolepsy type 1 have increased T-cell responses to orexins. Ann Clin Transl Neurol. 2019 12; 6(12):2566-2572.
Score: 0.055
-
Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia. J Clin Microbiol. 2019 08; 57(8).
Score: 0.054
-
Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region. J Neurovirol. 2019 08; 25(4):475-479.
Score: 0.053
-
PML-IRIS in an HIV-2-infected patient presenting as Bell's palsy. J Neurovirol. 2017 10; 23(5):789-792.
Score: 0.047
-
Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy. J Neurovirol. 2016 08; 22(4):464-71.
Score: 0.042
-
Brief Report: Role of Thymic Reconstitution in the Outcome of AIDS-Related PML. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):357-61.
Score: 0.042
-
Simian Virus 40 Infection in the Spinal Cord of Simian Immunodeficiency Virus-Immunosuppressed Rhesus Macaques. J Neuropathol Exp Neurol. 2015 Nov; 74(11):1071-6.
Score: 0.042
-
Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. J Neuropathol Exp Neurol. 2015 Aug; 74(8):791-803.
Score: 0.041
-
Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate. Ann Neurol. 2015 Oct; 78(4):501-14.
Score: 0.041
-
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Neurology. 2014 Aug 19; 83(8):727-32.
Score: 0.038
-
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol. 2014 Jun; 75(6):925-34.
Score: 0.038
-
Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy. Ann Neurol. 2014 May; 75(5):659-69.
Score: 0.038
-
Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation. Biol Blood Marrow Transplant. 2014 Jul; 20(7):992-9.
Score: 0.037
-
Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis. 2014 Jun; 58(12):1771-7.
Score: 0.037
-
Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome. Brain. 2013 Nov; 136(Pt 11):3441-50.
Score: 0.036
-
Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis. Neuropathology. 2014 Feb; 34(1):39-44.
Score: 0.035
-
A game of viral hide and seek: miliary PML masquerading as EBV encephalitis in an HIV+ patient. Clin Neurol Neurosurg. 2013 Sep; 115(9):1861-3.
Score: 0.035
-
Comment: avoiding detrimental effects of corticosteroids on JC virus T-cell responses--primum non nocere. Neurology. 2012 Dec 04; 79(23):2263.
Score: 0.034
-
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology. 2012 Nov 20; 79(21):2160; author reply 2160.
Score: 0.034
-
Metabolic profile of PML lesions in patients with and without IRIS: an observational study. Neurology. 2012 Sep 04; 79(10):1041-8.
Score: 0.034
-
Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):244-8.
Score: 0.033
-
JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant. PLoS One. 2012; 7(4):e35793.
Score: 0.033
-
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology. 2012 May 01; 78(18):1390-3.
Score: 0.033
-
Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology. 2012 Jan 03; 78(1):73; author response 73-4.
Score: 0.032
-
JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J Gen Virol. 2012 Jan; 93(Pt 1):175-183.
Score: 0.031
-
Hidden in plain view: emergence of progressive multifocal leukoencephalopathy after treatment of CNS toxoplasmosis. Acta Neurol Belg. 2011 Sep; 111(3):217-9.
Score: 0.031
-
JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis. 2011 Oct; 53(7):711-5.
Score: 0.031
-
Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2010 Nov; 81(11):1288-91.
Score: 0.029
-
The spectrum of neurological disorders in a Zambian tertiary care hospital. J Neurol Sci. 2010 Mar 15; 290(1-2):1-5.
Score: 0.028
-
Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009 Nov 10; 73(19):1551-8.
Score: 0.028
-
Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry. 2010 Mar; 81(3):247-54.
Score: 0.028
-
Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med. 2009 Sep 10; 361(11):1067-74.
Score: 0.027
-
Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol. 2009 Jan; 68(1):15-25.
Score: 0.026
-
Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirol. 2008 Oct; 14(5):455-8.
Score: 0.026
-
Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient. J Neurovirol. 2007 Oct; 13(5):474-6.
Score: 0.024
-
Remission of progressive multifocal leukoencephalopathy and primary central nervous system lymphoma in an HIV-infected patient. Eur J Neurol. 2007 Jun; 14(6):598-602.
Score: 0.023
-
Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells. J Neurovirol. 2006 Apr; 12(2):116-28.
Score: 0.022
-
Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology. 2006 Jan 24; 66(2):262-4.
Score: 0.021
-
Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies. AIDS. 2005 Dec 02; 19(18):2069-76.
Score: 0.021
-
Progressive multifocal leukoencephalopathy as a complication of hepatitis C virus treatment in an HIV-negative patient. Clin Infect Dis. 2005 Aug 01; 41(3):417-9.
Score: 0.021
-
Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology. 2004 Sep 14; 63(5):897-900.
Score: 0.019
-
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain. 2004 Sep; 127(Pt 9):1970-8.
Score: 0.019
-
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med. 2004 Apr 29; 350(18):1882-93.
Score: 0.019
-
Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology. 2003 Sep 23; 61(6):775-82.
Score: 0.018
-
Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol. 2003; 9 Suppl 1:25-31.
Score: 0.017
-
The case of a 42-year-old man with progressive gait instability, dysarthria, and dysphagia. Ann Clin Transl Neurol. 2023 01; 10(1):144-145.
Score: 0.017
-
Clinical presentation and outcomes of syphilitic meningitis among hospitalized adults in lusaka, Zambia. Int J STD AIDS. 2022 10; 33(12):1038-1044.
Score: 0.017
-
Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patients. Geroscience. 2022 06; 44(3):1241-1254.
Score: 0.016
-
Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy era. Epilepsia Open. 2022 06; 7(2):315-324.
Score: 0.016
-
Cross-protective immunity following coronavirus vaccination and coronavirus infection. J Clin Invest. 2021 12 15; 131(24).
Score: 0.016
-
Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy. JAMA Neurol. 2021 06 01; 78(6):736-740.
Score: 0.015
-
Abnormal movements in hospitalized COVID-19 patients: A case series. J Neurol Sci. 2021 04 15; 423:117377.
Score: 0.015
-
Transcranial Doppler Ultrasound Evidence of Active Cerebral Embolization in COVID-19. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105542.
Score: 0.015
-
Clinicopathological characterization of an HIV-2-infected individual with two clonally unrelated primary lymphomas. Am J Hematol. 2000 Dec; 65(4):302-6.
Score: 0.015
-
Brainstem progressive multifocal leukoencephalopathy. Eur J Neurol. 2021 03; 28(3):1016-1021.
Score: 0.015
-
Evaluating the impact of antiretroviral and antiseizure medication interactions on treatment effectiveness among outpatient clinic attendees with HIV in Zambia. Epilepsia. 2020 12; 61(12):2705-2711.
Score: 0.015
-
Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate. J Neurol. 2020 01; 267(1):125-131.
Score: 0.014
-
Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors. J Acquir Immune Defic Syndr. 2019 10 01; 82(2):220-224.
Score: 0.014
-
Neurosyphilis. Semin Neurol. 2019 08; 39(4):448-455.
Score: 0.014
-
Treatment of natalizumab-associated PML with filgrastim. Ann Clin Transl Neurol. 2019 May; 6(5):923-931.
Score: 0.013
-
Mortality & recurrent seizure risk after new-onset seizure in HIV-positive Zambian adults. BMC Neurol. 2018 Dec 07; 18(1):201.
Score: 0.013
-
Neurologic illness in Zambia: A neurointensivist's experience. J Neurol Sci. 2018 02 15; 385:140-143.
Score: 0.012
-
A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient. Transplantation. 2017 06; 101(6):1461-1467.
Score: 0.012
-
Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):246-255.
Score: 0.012
-
New-onset seizure in HIV-infected adult Zambians: A search for causes and consequences. Neurology. 2017 01 31; 88(5):477-482.
Score: 0.011
-
Fulminant Myocarditis with Combination Immune Checkpoint Blockade. N Engl J Med. 2016 Nov 03; 375(18):1749-1755.
Score: 0.011
-
JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. J Neurovirol. 2017 02; 23(1):141-146.
Score: 0.011
-
Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals. J Neurovirol. 2016 08; 22(4):541-5.
Score: 0.011
-
HIV and new onset seizures: slipping through the cracks in HIV care and treatment. HIV Med. 2016 Feb; 17(2):118-23.
Score: 0.010
-
Acute EEG findings in HIV-infected Zambian adults with new-onset seizure. Neurology. 2015 Mar 31; 84(13):1317-22.
Score: 0.010
-
BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation. Transpl Immunol. 2015 Mar; 32(2):116-20.
Score: 0.010
-
Cognitive impairment and psychiatric morbidity in HIV+ Zambians with new-onset seizure. Am J Trop Med Hyg. 2014 Dec; 91(6):1254-8.
Score: 0.010
-
JC polyomavirus granule cell neuronopathy in a patient treated with rituximab. JAMA Neurol. 2014 Apr; 71(4):487-9.
Score: 0.009
-
Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review. Pediatr Infect Dis J. 2014 Apr; 33(4):e99-105.
Score: 0.009
-
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013 Apr 09; 80(15):1430-8.
Score: 0.009
-
EEG findings in asymptomatic HIV. Neurology. 1993 Mar; 43(3 Pt 1):635-6.
Score: 0.009
-
Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology. 2011 Jul 19; 77(3):297-9.
Score: 0.008
-
A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection. N Engl J Med. 1990 Sep 27; 323(13):864-70.
Score: 0.007
-
Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry. 2006 Sep; 77(9):1079-82.
Score: 0.006
-
BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patient. Clin Infect Dis. 2002 Aug 01; 35(3):326-9.
Score: 0.004
-
BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med. 2001 Oct 25; 345(17):1250-5.
Score: 0.004
-
[Effect of antiretroviral treatment on early electroencephalographic and otoneurologic manifestations in HIV infection and prognostic importance of verified perturbations]. Neurophysiol Clin. 1997 Dec; 27(6):508-19.
Score: 0.003
-
Mesencephalic clefts with associated eye movement disorders. Arch Ophthalmol. 1996 Apr; 114(4):429-32.
Score: 0.003
-
Phylogenetic study of ten new HTLV-I strains from the Americas. AIDS Res Hum Retroviruses. 1994 Jan; 10(1):103-6.
Score: 0.002
-
Neuro-otological manifestations in different stages of HIV infection. Acta Otolaryngol Suppl. 1991; 481:515-21.
Score: 0.002